These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 24096700)

  • 1. Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?
    Paul S; Mahanta S
    Mol Cell Biochem; 2014 Jan; 386(1-2):45-61. PubMed ID: 24096700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?
    Sajjad MU; Samson B; Wyttenbach A
    Curr Pharm Biotechnol; 2010 Feb; 11(2):198-215. PubMed ID: 20166961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases.
    Arawaka S; Machiya Y; Kato T
    Curr Pharm Biotechnol; 2010 Feb; 11(2):158-66. PubMed ID: 20170473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System.
    van Noort JM; Bugiani M; Amor S
    CNS Neurol Disord Drug Targets; 2017; 16(3):244-256. PubMed ID: 27804858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of molecular chaperones in the nervous system.
    Ohtsuka K; Suzuki T
    Brain Res Bull; 2000 Sep; 53(2):141-6. PubMed ID: 11044589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease.
    Chai Y; Koppenhafer SL; Bonini NM; Paulson HL
    J Neurosci; 1999 Dec; 19(23):10338-47. PubMed ID: 10575031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
    Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
    Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of heat shock proteins during polyglutamine neurodegeneration: mechanisms and hypothesis.
    Wyttenbach A
    J Mol Neurosci; 2004; 23(1-2):69-96. PubMed ID: 15126694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock proteins and neuroprotection.
    Trivedi S
    Recent Pat DNA Gene Seq; 2007; 1(2):134-7. PubMed ID: 19075927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of heat shock proteins in cerebral cortical cultures by celastrol.
    Chow AM; Tang DW; Hanif A; Brown IR
    Cell Stress Chaperones; 2013 Mar; 18(2):155-60. PubMed ID: 22865541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKCγ in spinocerebellar ataxia type 14.
    Nakazono A; Adachi N; Takahashi H; Seki T; Hamada D; Ueyama T; Sakai N; Saito N
    J Biol Chem; 2018 Sep; 293(38):14758-14774. PubMed ID: 30093405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock proteins as potential targets for protective strategies in neurodegeneration.
    Kampinga HH; Bergink S
    Lancet Neurol; 2016 Jun; 15(7):748-759. PubMed ID: 27106072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock response and insulin-associated neurodegeneration.
    Urban MJ; Dobrowsky RT; Blagg BS
    Trends Pharmacol Sci; 2012 Mar; 33(3):129-37. PubMed ID: 22172248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of heat shock proteins in differentiated human neuronal cells following co-application of celastrol and arimoclomol.
    Deane CA; Brown IR
    Cell Stress Chaperones; 2016 Sep; 21(5):837-48. PubMed ID: 27273088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying chaperones to protein-misfolding disorders: molecular chaperones against α-synuclein in Parkinson's disease.
    Chaari A; Hoarau-Véchot J; Ladjimi M
    Int J Biol Macromol; 2013 Sep; 60():196-205. PubMed ID: 23748003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
    Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
    J Mol Med (Berl); 2006 Aug; 84(8):635-46. PubMed ID: 16741751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP70 and HSP90 in neurodegenerative diseases.
    Gupta A; Bansal A; Hashimoto-Torii K
    Neurosci Lett; 2020 Jan; 716():134678. PubMed ID: 31816334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications.
    Adachi H; Katsuno M; Waza M; Minamiyama M; Tanaka F; Sobue G
    Int J Hyperthermia; 2009 Dec; 25(8):647-54. PubMed ID: 20021225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones.
    Fujikake N; Nagai Y; Popiel HA; Okamoto Y; Yamaguchi M; Toda T
    J Biol Chem; 2008 Sep; 283(38):26188-97. PubMed ID: 18632670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock proteins in cancer - Known but always being rediscovered: Their perspectives in cancer immunotherapy.
    Mazurakova A; Solarova Z; Koklesova L; Caprnda M; Prosecky R; Khakymov A; Baranenko D; Kubatka P; Mirossay L; Kruzliak P; Solar P
    Adv Med Sci; 2023 Sep; 68(2):464-473. PubMed ID: 37926002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.